Vimarsana
Biggest News Aggregation in the World

Danielf Dilling News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Danielf Dilling. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Danielf Dilling Today - Breaking & Trending Today

ISHLT Elects New Board Members and Professional Community Leaders - Vimarsana News

ISHLT Elects New Board Members and Professional Community Leaders

/PRNewswire/ -- The International Society for Heart and Lung Transplantation (ISHLT) has announced the results of the 2022 member election for the 2023 Board...

Primary Care Doctors' Knowledge of IPF Could Speed Up Diagnoses - Vimarsana News

Primary Care Doctors' Knowledge of IPF Could Speed Up Diagnoses

Prompt diagnosis of idiopathic pulmonary fibrosis is essential to reduce mortality, and improving education of primary care providers can help.

Pulmonary and primary care experts aim to reduce the time to diagnose interstitial lung diseases - Vimarsana News

Pulmonary and primary care experts aim to reduce the time to diagnose interstitial lung diseases

The American College of Chest Physicians (CHEST) and Three Lakes Foundation are announcing a steering committee of experts in the fields of pulmonary medicine and primary care medicine to lead an initiative called Bridging Specialties™: Timely Diagnosis for ILD Patients.

ISHLT Elects New Board Members to Take Office in April 2022 - Vimarsana News

ISHLT Elects New Board Members to Take Office in April 2022

/PRNewswire/ -- The International Society of Heart and Lung Transplantation has announced the results of the member election for the 2022 Board of Directors....

Antibiotics no help for mysterious lung-scarring disease, large trial finds - Vimarsana News

Antibiotics no help for mysterious lung-scarring disease, large trial finds

The findings dash hopes that antimicrobials would benefit patients with life-threatening idiopathic pulmonary fibrosis. The trial, however, will still benefit the battle against the deadly lung disease, the researchers say.